# VALSARTAN AND HYDROCHLOROTHIAZIDE
> **ANDA203026** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX INC · Approved 2013-03-21
## Drug
- **FDA Application Number:** ANDA203026
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VALSARTAN AND HYDROCHLOROTHIAZIDE
- **Generic name:** Hydrochlorothiazide
- **Active ingredients:** HYDROCHLOROTHIAZIDE; VALSARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** APOTEX INC
- **First approval:** 2013-03-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203026)
---
*MORVS · CC0 1.0*